Newsletter

Notice of General Office of China Food and Drug Administration on Intensive Monitoring of Medical Device Adverse Events during the “13th Five Year Plan”

Updated: 2017/9/30

To the food and drug administration of each province, autonomous region and municipality, and Xinjiang Production and Construction Corps:


During the “12th Five Year Plan (FYP)”, CFDA organized and carried out intensive monitoring of adverse events on 100 varieties of medical devices, which played a positive role in ensuring safety in medical device use of the public, and explored and summarized the work method for intensive monitoring. During the “13th FYP”, CFDA will continue to carry out intensive monitoring of adverse events on 100 varieties of medical devices. CFDA hereby issues to you the work plan of intensive monitoring of medical device adverse events during the “13th FYP”, please follow the work plan. Meanwhile, relevant issues are hereby announced as follows:


To acquire the English translation version of this document, please send an email to info@codex-trans.com